Morgan Stanley’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.99M | Sell |
1,019,429
-512,714
| -33% | -$3.01M | ﹤0.01% | 3909 |
|
|
2025
Q1 | $12.9M | Sell |
1,532,143
-609,323
| -28% | -$5.11M | ﹤0.01% | 3110 |
|
|
2024
Q4 | $15.9M | Sell |
2,141,466
-1,132,591
| -35% | -$8.43M | ﹤0.01% | 2978 |
|
|
2024
Q3 | $19M | Buy |
3,274,057
+443,027
| +16% | +$2.57M | ﹤0.01% | 2848 |
|
|
2024
Q2 | $18.8M | Sell |
2,831,030
-461,038
| -14% | -$3.07M | ﹤0.01% | 2737 |
|
|
2024
Q1 | $43M | Sell |
3,292,068
-2,943,400
| -47% | -$38.4M | ﹤0.01% | 1897 |
|
|
2023
Q4 | $79.5M | Buy |
6,235,468
+6,021,962
| +2,821% | +$76.8M | ﹤0.01% | 1962 |
|
|
2023
Q3 | $2.8M | Sell |
213,506
-231,152
| -52% | -$3.03M | ﹤0.01% | 4154 |
|
|
2023
Q2 | $11.4M | Buy |
444,658
+27,944
| +7% | +$715K | ﹤0.01% | 3044 |
|
|
2023
Q1 | $10.5M | Buy |
416,714
+233,531
| +127% | +$5.88M | ﹤0.01% | 3097 |
|
|
2022
Q4 | $4.21M | Buy |
183,183
+94,320
| +106% | +$2.17M | ﹤0.01% | 3900 |
|
|
2022
Q3 | $1.96M | Buy |
88,863
+49,698
| +127% | +$1.1M | ﹤0.01% | 4442 |
|
|
2022
Q2 | $560K | Buy |
39,165
+18,878
| +93% | +$270K | ﹤0.01% | 5357 |
|
|
2022
Q1 | $384K | Sell |
20,287
-23,998
| -54% | -$454K | ﹤0.01% | 5565 |
|
|
2021
Q4 | $826K | Buy |
44,285
+40,675
| +1,127% | +$759K | ﹤0.01% | 5212 |
|
|
2021
Q3 | $97K | Buy |
3,610
+1,703
| +89% | +$45.8K | ﹤0.01% | 6401 |
|
|
2021
Q2 | $59K | Buy |
+1,907
| New | +$59K | ﹤0.01% | 6603 |
|